CN109180694A - 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法 - Google Patents

一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法 Download PDF

Info

Publication number
CN109180694A
CN109180694A CN201811064932.7A CN201811064932A CN109180694A CN 109180694 A CN109180694 A CN 109180694A CN 201811064932 A CN201811064932 A CN 201811064932A CN 109180694 A CN109180694 A CN 109180694A
Authority
CN
China
Prior art keywords
compound
preparation
formula
cell imaging
acac
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201811064932.7A
Other languages
English (en)
Other versions
CN109180694B (zh
Inventor
何文英
吴禄勇
李建玲
刘艳萍
冯华杰
丁国华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hainan Normal University
Original Assignee
Hainan Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hainan Normal University filed Critical Hainan Normal University
Priority to CN201811064932.7A priority Critical patent/CN109180694B/zh
Publication of CN109180694A publication Critical patent/CN109180694A/zh
Application granted granted Critical
Publication of CN109180694B publication Critical patent/CN109180694B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/107Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6486Measuring fluorescence of biological material, e.g. DNA, RNA, cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

本发明涉及一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法,所述制备方法包括如下步骤:将化合物1与化合物2溶于CH2Cl2中,在Fe(acac)3和Et3N的作用下得到式I化合物;其中化合物1与化合物2的摩尔比为1:0.8‑1.0,Fe(acac)3的摩尔用量为化合物1的0.10‑0.12倍,每毫摩尔化合物1使用CH2Cl2的体积为12‑15mL,使用Et3N的体积为0.5‑0.6mL。反应温度优选在室温下进行,反应时间优选20‑24小时。

Description

一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法
技术领域
本发明属于有机合成及细胞成像领域,具体涉及一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法。
背景技术
随着工业的迅速发展,带来经济效应的同时,所带来的污染对环境也构成了极大的威胁。而重金属离子Hg2+的污染更是不容忽视。汞作为最具毒害的重金属离子之一,被排放到土壤或水体中,通过食物链富集生命体造成威胁,因此而引发的各类疾病如阿尔茨海默症、水俣病、肢端疼痛症、尿毒症,已严重影响到人们的生活。基于1,2,3-三氮唑-罗丹明的荧光探针已有报道,但是尚未有该系列探针应用于细胞成像的报道。本发明提供一种由罗丹明酰肼与三氮唑羧酸酯一步法制备高灵敏度的Hg2+离子识别探针,并将该探针应用于细胞成像。
发明内容
本发明提供一种式I结构的罗丹明衍生物荧光探针,其特征在于式I结构如下:
本发明的另一实施方案提供上述式I化合物的制备方法,其特征在于包括如下步骤:
将化合物1与化合物2溶于CH2Cl2中,在Fe(acac)3和Et3N的作用下得到式I化合物;
其中化合物1与化合物2的摩尔比为1:0.8-1.0,Fe(acac)3的摩尔用量为化合物1的0.10-0.12倍,每毫摩尔化合物1使用CH2Cl2的体积为12-15mL,使用Et3N的体积为0.5-0.6mL。反应温度优选在室温下进行,反应时间优选20-24小时。
本发明的另一实施方案提供式I化合物在检测Hg2+中的应用。
本发明的另一实施方案提供式I化合物在HeLa细胞成像中的应用。
与现有技术相比,本发明的优点在于:本发明利用乙酰丙酮铁(Fe(acac)3)作为催化剂成功地实现了一步法合成罗丹明衍生物探针,且本发明合成的上述衍生物对Hg2+的检测灵敏度高,并能成功用于HeLa细胞成像。
附图说明
图1是式I化合物的1H NMR图;
图2是式I化合物的13C NMR图;
图3是式I化合物的HRMS图;
图4是式I化合物的荧光选择性图,激发波长为563nm;荧光滴定图,插图为584nm处体系的荧光强度变化;
图5是本发明实施例5的HeLa细胞活细胞荧光成像图。
具体实施方式
为了便于对本发明的进一步理解,下面提供的实施例对其做了更详细的说明。但是这些实施例仅供更好的理解发明而并非用来限定本发明的范围或实施原则,本发明的实施方式不限于以下内容。
实施例1
将化合物1(1.0mmol)与化合物2(0.8mmol)溶于CH2Cl2(12mL)中,室温下加入Fe(acac)3(0.1mmol)和Et3N(0.5mL),搅拌反应24小时,TLC检测原料完全消失,反应液浓缩后,进行硅胶柱层析(200-300目硅胶),用石油醚/乙酸乙酯(V:V=3:1~4:1)为洗脱剂,得式I化合物586mg,产率为91.3%。如图1所示:1H NMR(400MHz,CDCl3)δ8.40(s,1H),7.98(d,J=6.4Hz,1H),7.56–7.43(m,5H),7.38–7.35(m,2H),7.12(d,J=6.6Hz,1H),6.78(d,J=8.5Hz,2H),6.36(s,3H),6.33(s,1H),3.34(q,J=7.0Hz,8H),2.49(s,3H),1.16(t,J=7.0Hz,12H);13C NMR(100MHz,CDCl3)δ165.14,158.87,153.66,152.36,149.01,137.82,136.95,135.51,133.15,129.98,129.65,129.26,128.69,128.16,125.27,124.03,123.50,108.17,104.39,97.89,77.40,77.08,76.76,66.04,44.36,12.68,9.77.HRMS(ESI)(m/z):[M+H]+calcd for C38H40N7O3,642.3193;found,642.3199。
实施例2
将化合物1(1.0mmol)与化合物2(1.0mmol)溶于CH2Cl2(15mL)中,室温下加入Fe(acac)3(0.12mmol)和Et3N(0.6mL),搅拌反应20小时,TLC检测原料完全消失,反应液浓缩后,进行硅胶柱层析(200-300目硅胶),用石油醚/乙酸乙酯(V:V=3:1~4:1)为洗脱剂,得式I化合物592mg,产率为92.2%。
实施例3
将化合物1(1.0mmol)与化合物2(1.0mmol)溶于CH2Cl2(15mL)中,室温下加入Et3N(0.6mL),搅拌反应20小时后,TLC显示除化合物1和2外,未产生新的点(即没有发生反应)。
实施例4
如图4所示为检测在DMF-水(v/v=1:1,Tris–HCl,pH=7.4)溶液中,各离子(4×10-5mol/L)存在下式I探针(1×10-5mol/L)的荧光选择性图和对Hg2+荧光滴定光谱(inset)584nm处体系的荧光强度变化。荧光选择性图中在563nm激发光照射下,除了Hg2+,其他离子的加入均没有明显特征发射峰及颜色变化。加入Hg2+后,在584nm处荧光强度明显增强并伴有粉红色变化。荧光强度变化图式I探针(1×10-5mol/L)逐渐滴加Hg2+时的荧光光谱图。随着Hg2+的浓度增大,体系的荧光强度逐渐增大,当Hg2+浓度达到4.33×10-5mol/L时,体系荧光强度达到最大,此时Hg2+浓度为式I探针浓度的4.33倍。而当Hg2+浓度超过该浓度时,随着Hg2+浓度增大,体系荧光强度降低,在2.67×10-5~4.33×10-5mol/L浓度范围内荧光强度与Hg2+浓度呈线性相关,R2=0.95108。
实施例5细胞成像应用
在37℃的CO2细胞培养箱中培养HeLa细胞24小时进行实验。如图5所示,A.在DMEM培养液下HeLa细胞的亮场成像;B.在DMEM培养液下HeLa细胞的荧光成像;C.式I化合物在HeLa细胞的亮场成像;D.式I化合物在HeLa细胞的荧光成像;E.式I化合物在HeLa细胞对Hg2+的亮场成像;F.式I化合物在HeLa细胞对Hg2+的荧光成像的效果。式I化合物的浓度为1.0×10-5mol/L,加入Hg2+的浓度为2.67×10-5mol/L。上述实验结果表明本发明的式I化合物可用于细胞成像。

Claims (5)

1.一种式I结构的罗丹明衍生物荧光探针,其特征在于式I结构如下:
2.权利要求1所述的式I化合物的制备方法,其特征在于包括如下步骤:
将化合物1与化合物2溶于CH2Cl2中,在Fe(acac)3和Et3N的作用下得到式I化合物。
3.权利要求2所述的制备方法,其特征在于化合物1与化合物2的摩尔比为1:0.8-1.0,Fe(acac)3的摩尔用量为化合物1的0.10-0.12倍,每毫摩尔化合物1使用CH2Cl2的体积为12-15mL,使用Et3N的体积为0.5-0.6mL。
4.权利要求2-3任一项所述的制备方法,其特征在于反应温度优选在室温下进行,反应时间优选20-24小时。
5.权利要求1所述的式I化合物在HeLa细胞成像中的应用。
CN201811064932.7A 2018-09-12 2018-09-12 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法 Active CN109180694B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811064932.7A CN109180694B (zh) 2018-09-12 2018-09-12 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811064932.7A CN109180694B (zh) 2018-09-12 2018-09-12 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法

Publications (2)

Publication Number Publication Date
CN109180694A true CN109180694A (zh) 2019-01-11
CN109180694B CN109180694B (zh) 2020-12-29

Family

ID=64910689

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811064932.7A Active CN109180694B (zh) 2018-09-12 2018-09-12 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法

Country Status (1)

Country Link
CN (1) CN109180694B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113637027A (zh) * 2021-07-22 2021-11-12 海南师范大学 一种苯基三氮唑二羧酸-罗丹明b衍生物荧光探针及其制备方法与应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746313A (zh) * 2012-06-20 2012-10-24 山东大学 含1,2,4-三唑结构单元的罗丹明b酰肼衍生物及其制备方法与应用

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746313A (zh) * 2012-06-20 2012-10-24 山东大学 含1,2,4-三唑结构单元的罗丹明b酰肼衍生物及其制备方法与应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SHIUE-SHIEN WENG ET AL.: "Transesterification catalyzed by iron(III)-diketonate species", 《TETRAHEDRON》 *
丁国华: "系列1,2,3-三氮唑化合物与罗丹明B的合成、显色反应及其球状蛋白的相互作用", 《海南师范大学硕士学位论文》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113637027A (zh) * 2021-07-22 2021-11-12 海南师范大学 一种苯基三氮唑二羧酸-罗丹明b衍生物荧光探针及其制备方法与应用
CN113637027B (zh) * 2021-07-22 2022-04-05 海南师范大学 一种苯基三氮唑二羧酸-罗丹明b衍生物荧光探针及其制备方法与应用

Also Published As

Publication number Publication date
CN109180694B (zh) 2020-12-29

Similar Documents

Publication Publication Date Title
He et al. A ratiometric fluorescent formaldehyde probe for bioimaging applications
Zhang et al. A two-photon excited luminescence of water-soluble rhodamine–platinum (II) complex: fluorescent probe specific for Hg2+ detection in live cell
Duan et al. A ratiometric fluorescent probe for gasotransmitter hydrogen sulfide based on a coumarin-benzopyrylium platform
CN104860879B (zh) 一种丙二腈异佛尔酮类铜离子荧光探针及其制备方法
CN107383037B (zh) 一种长波长型h2s荧光探针及其合成方法和应用
Huang et al. A rhodamine-based “turn-on” fluorescent chemodosimeter for Cu2+ and its application in living cell imaging
CN109735328A (zh) 一种检测细胞内硫化氢的荧光探针及其制备方法和应用
Qu et al. A fluorescence “switch-on” approach to detect hydrazine in aqueous solution at neutral pH
CN109336815B (zh) 一种检测细胞内质网内次氯酸的双光子荧光探针
Hou et al. A colorimetric and red emissive fluorescent probe for cysteine and its application in bioimaging
Zhang et al. A rhodamine hydrazide-based fluorescent probe for sensitive and selective detection of hypochlorous acid and its application in living cells
CN107286151B (zh) 一种基于咔唑的双光子荧光探针及其制备方法和用途
CN110373181B (zh) 一种检测氟离子的荧光探针
CN109021000B (zh) 一种检测过氧化氢的荧光探针、合成方法和应用
CN108948033B (zh) 一种用于检测Hg2+的罗丹明衍生物荧光探针及其制备方法与应用
CN109180694A (zh) 一种用于细胞成像的罗丹明衍生物荧光探针及其制备方法
CN108218881B (zh) 基于罗丹明b的汞离子荧光探针及其制备方法与应用
CN105669689A (zh) 一种基于罗丹明b的汞离子荧光探针化合物的制备与应用
Wadhavane et al. Fluorescent macrocyclic probes with pendant functional groups as markers of acidic organelles within live cells
CN110642857B (zh) 一种用于检测粘度和pH的双功能荧光探针及其制备与应用
CN108774226A (zh) 一种用于检测银离子的荧光探针及其制备方法与应用
CN109020988A (zh) 一种新型三氮唑类化合物的罗丹明荧光探针在Hela细胞成像中的应用
CN108948032B (zh) 2,5-二苯基-2h-1,2,3-三氮唑-4-羧酸罗丹明b衍生物的合成及其应用
CN111793029A (zh) 一种萘酰亚胺类甲醛荧光探针、制备方法及应用
CN108997255A (zh) 一种乙烯基醚类Hg2+荧光探针及其制备方法和应用

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant